(Q43985629)

28 November 2017

title

Biodegradable microsphere-loaded tacrolimus enhanced the effect on mice islet allograft and reduced the adverse effect on insulin secretion (English)

1 reference

biodegradable microsphere

28 November 2017

0 references

1 reference

1 reference

Quanxing Wang

1

1 reference

28 November 2017

Takeji Uno

2

1 reference

28 November 2017

Yasunori Miyamoto

3

1 reference

28 November 2017

Yuko Hara

4

1 reference

28 November 2017

Yusuke Kitazawa

5

1 reference

28 November 2017

Fei-Zhou Lu

6

1 reference

28 November 2017

Naoko Funeshima

7

1 reference

28 November 2017

Masayuki Fujino

8

1 reference

28 November 2017

Hiromitsu Yamamoto

9

1 reference

28 November 2017

Hirofumi Takenaka

10

1 reference

28 November 2017

Yoshiaki Kawashima

11

1 reference

28 November 2017

Xiao-Kang Li

12

1 reference

28 November 2017

language of work or name

English

0 references

publication date

1 May 2004

1 reference

American Journal of Transplantation

28 November 2017

published in

1 reference

28 November 2017

volume

4

1 reference

28 November 2017

issue

5

1 reference

28 November 2017

page(s)

721-727

1 reference

Tacrolimus rescue therapy for renal allograft rejection--five-year experience

28 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00423.X

Tacrolimus in pediatric renal transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00423.X

Immunosuppression with sirolimus/tacrolimus combination in pancreas transplantation: 1-year results

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00423.X

Reduced dose Thymoglobulin, tacrolimus, and mofetil mycophenolate results in excellent solitary pancreas transplantation outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00423.X

Role of steroid dose in hypertension early after liver transplantation with tacrolimus (FK506) and cyclosporine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00423.X

Peripheral neurotoxicity with tacrolimus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00423.X

Microangiopathic hemolytic anemia complicating FK506 (tacrolimus) therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00423.X

Defining optimal immunosuppression for islet transplantation based on reduced diabetogenicity in canine islet autografts

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00423.X

Daclizumab and ATG versus ATG in combination with tacrolimus, mycophenolate mofetil, and steroids in simultaneous [correction of simultaneus] pancreas-kidney transplantation: analysis of early outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00423.X

Ethnic disparity in clinical outcome after heart transplantation is abrogated using tacrolimus and mycophenolate mofetil-based immunosuppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00423.X

A multicenter, open-label, comparative trial of two daclizumab dosing strategies vs. no antibody induction in combination with tacrolimus, mycophenolate mofetil, and steroids for the prevention of acute rejection in simultaneous kidney-pancreas tran

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00423.X

Liposomal encapsulation significantly enchances the immunosuppressive effect of tacrolimus in a discordant islet xenotransplant model

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00423.X

Tacrolimus reversibly reduces insulin secretion in paediatric renal transplant recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00423.X

Solvent evaporation processes for the production of controlled release biodegradable microsphere formulations for therapeutics and vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00423.X

Biodegradable nanoparticles as a delivery system for cyclosporine: preparation and characterization

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00423.X

Pharmacokinetics of tacrolimus (FK506) in paediatric liver transplant recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00423.X

FK-506, a novel immunosuppressant isolated from a Streptomyces. II. Immunosuppressive effect of FK-506 in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00423.X

Synthesis and pharmacokinetics of a novel macromolecular prodrug of Tacrolimus (FK506), FK506-dextran conjugate

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00423.X

POTENTIAL FOR IMPROVED THERAPEUTIC INDEX OF FK506 IN LIPOSOMAL FORMULATION DEMONSTRATED IN A MOUSE CARDIAC ALLOGRAFT MODEL1,2

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00423.X

Increased incidence of insulin-dependent diabetes mellitus in pediatric renal transplant patients receiving tacrolimus (FK506)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00423.X

Modification of release rates of cyclosporin A from polyl(L-lactic acid) microspheres by fatty acid esters and in-vivo evaluation of the microspheres

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00423.X

Diabetes mellitus after renal transplantation: characteristics, outcome, and risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00423.X

Effects of cyclosporin on prednisolone metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00423.X

10.1111/J.1600-6143.2004.00423.X

21 January 2018

Identifiers

DOI

1 reference

28 November 2017

1 reference